These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 586099
1. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail. Lau WK, Young LS, Black RE, Winston DJ, Linne SR, Weinstein RJ, Hewitt WL. Am J Med; 1977 Jun; 62(6):959-66. PubMed ID: 586099 [No Abstract] [Full Text] [Related]
5. A prospective, randomized study of amikacin and gentamicin in serious infections with focus on efficacy, toxicity and duration of serum levels above the MIC. Holm SE, Hill B, Löwestad A, Maller R, Vikerfors T. J Antimicrob Chemother; 1983 Oct 17; 12(4):393-402. PubMed ID: 6643334 [Abstract] [Full Text] [Related]
6. Amikacin therapy of gram-negative bacteremia. Tally FP, Gorbach SL. Am J Med; 1977 Jun 17; 62(6):936-9. PubMed ID: 868909 [Abstract] [Full Text] [Related]
8. [A case of E. coli septicemia successfully treated with amikacin (author's transl)]. Ueda Y, Matsumoto F, Saito A, Saigusa M. Jpn J Antibiot; 1975 Oct 17; 28(5):655-6. PubMed ID: 1100873 [No Abstract] [Full Text] [Related]
10. Aminoglycoside-related nephrotoxicity in the premature newborn. Rajchgot P, Prober CG, Soldin S, Perlman M, Good F, Harding E, Klein J, MacLeod S. Clin Pharmacol Ther; 1984 Mar 17; 35(3):394-401. PubMed ID: 6365403 [Abstract] [Full Text] [Related]
12. Amikacin. Gleckman R. Am Fam Physician; 1976 Dec 17; 14(6):75. PubMed ID: 998471 [No Abstract] [Full Text] [Related]
13. Amikacin therapy for gram-negative septicemia. Meyer RD, Lewis RP, Finegold SM. Am J Med; 1977 Jun 17; 62(6):930-5. PubMed ID: 868908 [Abstract] [Full Text] [Related]
14. Amikacin therapy for serious gram-negative infection. Pollock AA, Berger SA, Richmond AS, Simberkoff MS, Rahal JJ. JAMA; 1977 Feb 07; 237(6):562-4. PubMed ID: 576282 [Abstract] [Full Text] [Related]
15. Significance of antimicrobial synergism for the outcome of gram negative sepsis. Klastersky J, Meunier-Carpentier F, Prevost JM. Am J Med Sci; 1977 Feb 07; 273(2):157-67. PubMed ID: 324279 [Abstract] [Full Text] [Related]
16. Amikacin therapy. Use against infections caused by gentamicin- and tobramycin-resistant organisms. Yu VL, Rhame FS, Pesanti EL, Axline SG. JAMA; 1977 Aug 29; 238(9):943-7. PubMed ID: 328950 [Abstract] [Full Text] [Related]
17. Comparative ototoxicity of BB-K8 (amikacin), gentamicin, sisomicin and tobramycin in the guinea pig. Brummett RE, Fox KE. Proc West Pharmacol Soc; 1977 Aug 29; 20():449-53. PubMed ID: 896854 [No Abstract] [Full Text] [Related]
19. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin. Lerner SA, Schmitt BA, Seligsohn R, Matz GJ. Am J Med; 1986 Jun 30; 80(6B):98-104. PubMed ID: 3524221 [Abstract] [Full Text] [Related]
20. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study. Fong IW, Fenton RS, Bird R. J Antimicrob Chemother; 1981 Jan 30; 7(1):81-8. PubMed ID: 7204294 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]